Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

Quest Diagnostics

Quest and Walmart to Expand Consumer-Initiated Test Options

SERVING CONSUMERS INTERESTED IN ORDERING THEIR OWN CLINICAL LABORATORY TESTS is a goal in an expanded collaboration involving Quest Diagnostics and Walmart. This is also consistent with The Dark Report’s prediction that retail pharmacies are poised to expand the diagnostic testing ser…

Read More



Expert Lists Strategies to Cope with Cyber Attacks

CEO SUMMARY: Class action lawsuits filed by patients whose protected health information (PHI) was breached during a cyber attack may be one additional unwelcome consequence for clinical laboratories and anatomic pathology groups hit by a ransomware or cyber attack. This is what happ…

Read More



January 10, 2022 Intelligence: Late-Breaking Lab News

Imagine a medical lab temporarily closing because of the demand for too many tests! That’s just what happened at one of Australia’s largest medical lab companies. Australian Clinical Labs had to temporarily discontinue offering COVID-19 testing because test volumes had gotten too large. Au…

Read More



November 8, 2021 Intelligence: Late-Breaking Lab News

Last week, the state of California auto-renewed its controversial COVID-19 testing contract with PerkinElmer to run the Valencia Branch Laboratory. Designed, built, and operated by PerkinElmer, the lab began SARS-CoV-2 testing in the fall of 2020 and immediately was in the news for a range of …

Read More



New Class of IVD Firms Wants to Serve POCT in Near-Patient Settings

CEO SUMMARY: Our second installment in this series describes an emerging new clas…

Read More



September 7, 2021 Intelligence: Late-Breaking Lab News

New diagnoses of cancer in the United States fell by almost 30% in the early months of the SARS-CoV-2 pandemic. That’s one conclusion in a paper authored by Quest Diagnostics and published on Aug. 31, in JAMA Network Open. Quest looked at the new diagnoses of eight common types of can…

Read More



India’s Neuberg Diagnostics Expands into U.S. Market

“Our idea is to enhance the access and affordability for next-generation techniques, meaning molecular diagnostics, genomics, pathology, digital pathology, proteomics, metabolomics, and all that. This is the spirit behind Neuberg Diagnostics. —GSK Velu, PhD, BPharm …

Read More



Goodbye Clinical Labs! Hello Genetic Testing Labs!

IS THE CLASSIC MODEL OF THE INDEPENDENT PATHOLOGIST-OWNED CLINICAL LABORATORY that is the sole source provider of all routine, reference, and esoteric testing to physicians in its community on its way to extinction? There is strong evidence to support a “yes” answer to that question….

Read More



CLIA Accreditation Market: More Competitive Now?

CEO SUMMARY: It’s been three decades since compliance with the Clinical Laboratory Improvement Amendments (CLIA) became mandatory. During that time, there has been little competition among the major organizations with deeming status by the Medicare Program to accredit labs to CLIA…

Read More



July 26, 2021 Intelligence: Late-Breaking Lab News

Intermountain Healthcare of Salt Lake City announced that it plans to close 25 of its 26 retail pharmacies as early as next month. It cited declining business and a new business arrangement with CVS Health, the national pharmacy chain. Daron Crowley, Intermountain’s media relations di…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;